HIGH SUSANNA GATTI
SEC insider (Form 3/4/5 filer). CIK 0001691005. Chief Operating Officer at Dyne Therapeutics, Inc. (DYN). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2024. Located in WALTHAM, MA.
Companies HIGH SUSANNA GATTI has filed insider reports for
- Dyne Therapeutics, Inc. (DYN): Officer, Chief Operating Officer
HIGH SUSANNA GATTI
CIK: 0001691005
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DYN
Dyne Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 18, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect4.3K shares at avg. $34.41$149K - Sep 18, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect4.6K shares at avg. $34.41$160K - Sep 11, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect2.5K shares at avg. $31.89$81K - Sep 11, 2024DYN
Dyne Therapeutics, Inc.
SaleDirect2.7K shares at avg. $31.89$87K
1-4 of 4 transactions